Literature DB >> 22449621

Eosinophils and disease pathogenesis.

Praveen Akuthota1, Peter F Weller.   

Abstract

Eosinophils are granulocytic innate immune cells whose presence is conspicuous in a variety of disease states, including eosinophilic hyperproliferative and infiltrative processes, as well as conditions associated with maladaptive Th2 inflammation. This review discusses the role of eosinophils in disease pathogenesis, including a consideration of relevant eosinophil biology. Eosinophilic disease patterns of tissue infiltration are also detailed, as are candidate mechanisms by which eosinophils cause fibrosis and hypercoagulability and the importance of eosinophils in allergic inflammation. Eosinophils are unique cells in their spectrum of associated disease, with the promise of future discoveries in delineating the manner in which they contribute to disease pathogenesis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22449621      PMCID: PMC3571705          DOI: 10.1053/j.seminhematol.2012.01.005

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  84 in total

1.  Eosinophils from patients with blood eosinophilia express transforming growth factor beta 1.

Authors:  D T Wong; A Elovic; K Matossian; N Nagura; J McBride; M Y Chou; J R Gordon; T H Rand; S J Galli; P F Weller
Journal:  Blood       Date:  1991-11-15       Impact factor: 22.113

Review 2.  The idiopathic hypereosinophilic syndrome.

Authors:  P F Weller; G J Bubley
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

3.  Release of granule proteins from eosinophils cultured with IL-5.

Authors:  H Kita; D A Weiler; R Abu-Ghazaleh; C J Sanderson; G J Gleich
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

4.  Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease.

Authors:  A Slungaard; G M Vercellotti; T Tran; G J Gleich; N S Key
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

5.  Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis.

Authors:  H Noguchi; G M Kephart; T V Colby; G J Gleich
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

6.  Eosinophils adhere to and stimulate replication of lung fibroblasts 'in vitro'.

Authors:  A Shock; K F Rabe; G Dent; R C Chambers; A J Gray; K F Chung; P J Barnes; G J Laurent
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

7.  Modulation of eosinophil chemotaxis by interleukin-5.

Authors:  R A Warringa; R C Schweizer; T Maikoe; P H Kuijper; P L Bruijnzeel; L Koendermann
Journal:  Am J Respir Cell Mol Biol       Date:  1992-12       Impact factor: 6.914

8.  Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors.

Authors:  T Kitamura; N Sato; K Arai; A Miyajima
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

9.  A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF.

Authors:  J Tavernier; R Devos; S Cornelis; T Tuypens; J Van der Heyden; W Fiers; G Plaetinck
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

10.  Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils.

Authors:  H Kita; T Ohnishi; Y Okubo; D Weiler; J S Abrams; G J Gleich
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

View more
  20 in total

1.  Dusp5 negatively regulates IL-33-mediated eosinophil survival and function.

Authors:  Derek A Holmes; Jung-Hua Yeh; Donghong Yan; Min Xu; Andrew C Chan
Journal:  EMBO J       Date:  2014-11-14       Impact factor: 11.598

Review 2.  Eosinophilic Skin Diseases: A Comprehensive Review.

Authors:  Hai Long; Guiying Zhang; Ling Wang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667

3.  Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome.

Authors:  Julie M Caldwell; Margaret H Collins; Emily M Stucke; Philip E Putnam; James P Franciosi; Jonathan P Kushner; J Pablo Abonia; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2014-09-15       Impact factor: 10.793

Review 4.  Spectrum of Eosinophilic End-Organ Manifestations.

Authors:  Praveen Akuthota; Peter F Weller
Journal:  Immunol Allergy Clin North Am       Date:  2015-06-17       Impact factor: 3.479

5.  Type-2 Cytokines Promote the Secretion of the Eosinophil-Attractant CCL26 by Intestinal Epithelial Cells in Food-Sensitized Patients.

Authors:  Julián Vaccaro; Karina Eva Canziani; Luciana Guzmán; Viviana Bernedo; Marcela García; Eugenia Margarita Altamirano; Emanuel Feregotti; Renata Curciarello; Cecilia Isabel Muglia; Guillermo Horacio Docena
Journal:  Front Immunol       Date:  2022-06-21       Impact factor: 8.786

6.  Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.

Authors:  Michael E Wechsler; Praveen Akuthota; David Jayne; Paneez Khoury; Amy Klion; Carol A Langford; Peter A Merkel; Frank Moosig; Ulrich Specks; Maria C Cid; Raashid Luqmani; Judith Brown; Stephen Mallett; Richard Philipson; Steve W Yancey; Jonathan Steinfeld; Peter F Weller; Gerald J Gleich
Journal:  N Engl J Med       Date:  2017-05-18       Impact factor: 91.245

7.  Ovalbumin enhances YKL-40, IL-5, GM-CSF, and eotaxin expression simultaneously in primarily cultured mouse tracheal epithelial cells.

Authors:  Su-qin Ben; Ya-li Qiu; Juan Zhou; Xiao-yu Zhou; Shan Zhang; Yi Wu; Shao-qing Ju; Song-shi Ni
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-10-19       Impact factor: 2.416

8.  Myenteric plexitis: A frequent feature in patients undergoing surgery for colonic diverticular disease.

Authors:  Gabrio Bassotti; Vincenzo Villanacci; Angelo Sidoni; Riccardo Nascimbeni; Maria P Dore; Gian A Binda; Roberto Bandelloni; Marianna Salemme; Rachele Del Sordo; Moris Cadei; Alessandra Manca; Nunzia Bernardini; Christoph A Maurer; Gieri Cathomas
Journal:  United European Gastroenterol J       Date:  2015-12       Impact factor: 4.623

Review 9.  Reversibility of Stricturing Crohn's Disease-Fact or Fiction?

Authors:  Dominik Bettenworth; Florian Rieder
Journal:  Inflamm Bowel Dis       Date:  2016-01       Impact factor: 5.325

10.  Targeted ablation of miR-21 decreases murine eosinophil progenitor cell growth.

Authors:  Thomas X Lu; Eun-Jin Lim; Svetlana Itskovich; John A Besse; Andrew J Plassard; Melissa K Mingler; Joelle A Rothenberg; Patricia C Fulkerson; Bruce J Aronow; Marc E Rothenberg
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.